Carlsbad, Calif.-based Verdezyne Inc., has signed agreements with two distributors for Biolon™ biobased dodecanedioic acid (DDDA) produced at its new commercial-scale plant currently under construction in Malaysia. The Netherlands-based Will & Co. will sell and distribute Biolon in Europe. The agreement gives 25-percent of the expected plant capacity to Will & Co. Verdezyne signed a second deal with San Francisco-based Connell Bros. Co. LLC, for 10-percent of the plant’s expected capacity, which will be distributed in 17 countries throughout the Asia-Pacific region.
The facility is expected to be complete in 2017 with an annual capacity of up to 9,000 metric tons of diacids, including Biolon.
March/April 2016
